Národní úložiště šedé literatury Nalezeno 5 záznamů.  Hledání trvalo 0.01 vteřin. 
Role genu WT1 v normální hematopoese a leukemogenese
Kramarzová, Karolina ; Trka, Jan (vedoucí práce) ; Zadražil, Stanislav (oponent)
6 Abstract The Wilms' tumor gene is highly expressed in a large proportion of human acute leukemias and other hematological malignancies. It is thought to play an important role in human hematpoiesis and leukemogenesis. Despite the large number of studies, WT1 expression patterns and its clinical significance in acute myeloid leukemia remain still controversial. To investigate the prognostic relevance of initial WT1 expression and its usefulness as a marker for minimal residual disease, we have analysed 66 bone marrow samples from newly diagnosed AML patients. RQ-RT-PCR for absolute quantification of total WT1 was designed according to Europe Against Cancer Program. In 82 % of samples we detected a higher expression of WT1 compared to normal healthy donors or patients with acute lymphoblastic leukemia (p<0.0001). We did not find any correlation between initial WT1 expression level and age or sex. Patients with FAB M3 subtype showed significantly higher WT1 levels than other subtypes, especially M5 (p<0.001). We found a strikingly high WT1 expression in standard risk group patients compared to high risk group (p<0.0007). Children with FAB/cytogenetical favorable prognostic factors have high WT1 expression, while there was no relation between WT1 levels at diagnosis and day 15 BM response. We did not find any...
Studium variabilního úseku onkoproteinu v-Myb
Starostová, Michaela ; Dvořák, Michal (vedoucí práce) ; Zadražil, Stanislav (oponent)
- 4 - Study of the v-Myb oncoprotein variable region The aim of this thesis was to analyze the significance of the variable region of oncoprotein v-Myb. The v-myb oncogene originated in the chick through a natural recombination of the MAV1 retroviral genome with the c-myb gene, which is an important transcriptional regulator involved in hematopoiesis and other important processes in different types of vertebrate cells. In comparison with the c-myb coding sequence, the retroviral v-myb is truncated on N- and C-terminals and includes 11 point mutations. Due to both these changes and the retroviral promoter which drives its expresion, the v-Myb oncoprotein became the inducer of acute myeloid leukemia in chicks. The variable region of v-Myb lies in between the N-terminal DNA binding and the central transactivating domains. This region is the least evolutionarily conserved part of the protein. No published data are available about its potential function. In this work the biological significance of the variable region was studied by means of specific deletions and sequence swaps. Two deletions (∆PstI and ∆NaeI) and two swaps (chicken v-myb to mouse and Xenopus c-myb) were prepared. Recombinant DNAs were cloned into MAV1-based retroviral vector and transfected into chick embryo fibroblasts (CEFs) in tissue...
Role genu WT1 v normální hematopoese a leukemogenese
Kramarzová, Karolina ; Trka, Jan (vedoucí práce) ; Zadražil, Stanislav (oponent)
6 Abstract The Wilms' tumor gene is highly expressed in a large proportion of human acute leukemias and other hematological malignancies. It is thought to play an important role in human hematpoiesis and leukemogenesis. Despite the large number of studies, WT1 expression patterns and its clinical significance in acute myeloid leukemia remain still controversial. To investigate the prognostic relevance of initial WT1 expression and its usefulness as a marker for minimal residual disease, we have analysed 66 bone marrow samples from newly diagnosed AML patients. RQ-RT-PCR for absolute quantification of total WT1 was designed according to Europe Against Cancer Program. In 82 % of samples we detected a higher expression of WT1 compared to normal healthy donors or patients with acute lymphoblastic leukemia (p<0.0001). We did not find any correlation between initial WT1 expression level and age or sex. Patients with FAB M3 subtype showed significantly higher WT1 levels than other subtypes, especially M5 (p<0.001). We found a strikingly high WT1 expression in standard risk group patients compared to high risk group (p<0.0007). Children with FAB/cytogenetical favorable prognostic factors have high WT1 expression, while there was no relation between WT1 levels at diagnosis and day 15 BM response. We did not find any...

Chcete být upozorněni, pokud se objeví nové záznamy odpovídající tomuto dotazu?
Přihlásit se k odběru RSS.